Skandinaviska Enskilda Banken (SEB)
CBPO

Skandinaviska Enskilda Banken (SEB)’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,275
Closed -$506K – 1184
2021
Q1 		$506K Hold
4,275
– – ﹤0.01% 929
2020
Q4 		$505K Buy
+4,275
New +$496K ﹤0.01% 911
2020
Q2 		– Sell
-121,319
Closed -$13.1M – 1118
2020
Q1 		$13.1M Buy
+121,319
New +$13.9M 0.13% 149
2019
Q1 		– Sell
-39,900
Closed -$3.03M – 796
2018
Q4 		$3.03M Sell
39,900
-500
-1% -$36.8K 0.03% 367
2018
Q3 		$3.23M Buy
+40,400
New +$3.76M 0.02% 384
2017
Q3 		– Sell
-36,300
Closed -$4.11M – 763
2017
Q2 		$4.11M Sell
36,300
-8,600
-19% -$961K 0.04% 329
2017
Q1 		$4.5M Buy
+44,900
New +$4.8M 0.05% 303
2016
Q2 		– Sell
-57,800
Closed -$6.62M – 738
2016
Q1 		$6.62M Buy
+57,800
New +$6.78M 0.07% 198

Skandinaviska Enskilda Banken (SEB)'s CBPO Position: Q2 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 4,275 shares — an estimated $506K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in CBPO in Q1 2016 and held it in 8 quarters. The position peaked at $13.1M in Q1 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 4,275 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $506K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 8 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s China Biologic Products Holdings, Inc. position peaked at $13.1M in Q1 2020.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2021, filed 10 Aug 2021.